CN Patent

CN105530929B — 3‑羧基‑n‑乙基‑n,n‑二甲基丙‑1‑铵或其药学上可接受的盐在预防和治疗糖尿病中的用途

Assigned to Grindeks A Jsc · Expires 2018-03-02 · 8y expired

What this patent protects

本发明涉及3‑羧基‑N‑乙基‑N,N‑二甲基丙‑1‑铵及其药学上可接受的盐降低血浆胰岛素和葡萄糖水平的用途。

USPTO Abstract

本发明涉及3‑羧基‑N‑乙基‑N,N‑二甲基丙‑1‑铵及其药学上可接受的盐降低血浆胰岛素和葡萄糖水平的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN105530929B
Jurisdiction
CN
Classification
—
Expires
2018-03-02
Drug substance claim
No
Drug product claim
No
Assignee
Grindeks A Jsc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.